Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,902 | 613 | 99.8% |
| Education | $22.43 | 5 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,198 | 68 | $0 (2024) |
| Novo Nordisk Inc | $1,051 | 72 | $0 (2024) |
| PFIZER INC. | $705.52 | 47 | $0 (2024) |
| ABBVIE INC. | $554.11 | 35 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $522.04 | 24 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $471.51 | 29 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $442.18 | 32 | $0 (2024) |
| Lilly USA, LLC | $435.04 | 29 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $422.99 | 29 | $0 (2024) |
| Allergan, Inc. | $385.63 | 27 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,103 | 50 | Otsuka America Pharmaceutical, Inc. ($225.28) |
| 2023 | $1,217 | 64 | AstraZeneca Pharmaceuticals LP ($161.38) |
| 2022 | $1,228 | 70 | Otsuka America Pharmaceutical, Inc. ($144.20) |
| 2021 | $1,653 | 104 | AbbVie Inc. ($356.84) |
| 2020 | $1,289 | 83 | AstraZeneca Pharmaceuticals LP ($234.73) |
| 2019 | $988.35 | 65 | Allergan Inc. ($122.57) |
| 2018 | $1,521 | 112 | Novo Nordisk Inc ($254.87) |
| 2017 | $924.57 | 70 | Novo Nordisk Inc ($161.96) |
All Payment Transactions
618 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: NEUROLOGY | ||||||
| 12/18/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $26.66 | General |
| Category: Neurology | ||||||
| 12/14/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $27.42 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $26.72 | General |
| Category: PSYCHIATRY | ||||||
| 11/06/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $19.95 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 10/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.78 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $31.61 | General |
| Category: Neurology | ||||||
| 10/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: Respiratory | ||||||
| 10/09/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 10/03/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $34.06 | General |
| Category: PSYCHIATRY | ||||||
| 09/20/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/18/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: VACCINES | ||||||
| 09/11/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: Endocrinology | ||||||
| 09/06/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $22.13 | General |
| 09/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: Respiratory | ||||||
| 08/28/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: Diabetes | ||||||
| 08/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: NEUROSCIENCE | ||||||
| 08/21/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $17.43 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 08/15/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: PSYCHIATRY | ||||||
| 08/09/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: PSYCHIATRY | ||||||
| 08/08/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: Gastroenterology | ||||||
| 08/07/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: Neuromodulation | ||||||
| 08/07/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 323 | 787 | $106,773 | $46,001 |
| 2022 | 8 | 364 | 750 | $102,543 | $42,449 |
| 2021 | 13 | 566 | 1,048 | $130,187 | $58,941 |
| 2020 | 13 | 721 | 1,286 | $171,922 | $76,010 |
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 100 | 422 | $48,029 | $21,089 | 43.9% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 74 | 115 | $17,121 | $8,421 | 49.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 39 | 84 | $15,000 | $6,120 | 40.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 42 | 97 | $12,270 | $4,559 | 37.2% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 56 | 57 | $11,871 | $4,374 | 36.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 12 | 12 | $2,482 | $1,439 | 58.0% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 106 | 324 | $37,520 | $14,007 | 37.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 64 | 168 | $20,966 | $8,310 | 39.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 46 | 94 | $17,086 | $7,842 | 45.9% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Facility | 2022 | 61 | 62 | $13,378 | $5,663 | 42.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 24 | 24 | $5,160 | $3,005 | 58.2% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 36 | 45 | $6,966 | $2,345 | 33.7% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 15 | 21 | $1,107 | $1,068 | 96.5% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 12 | 12 | $360.00 | $210.39 | 58.4% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 113 | 331 | $37,949 | $16,575 | 43.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 66 | 188 | $22,682 | $10,303 | 45.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 64 | 112 | $19,925 | $8,095 | 40.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 41 | 41 | $8,383 | $5,136 | 61.3% |
| 99305 | Initial nursing facility visit, typically 35 minutes per day | Facility | 2021 | 54 | 56 | $12,153 | $4,939 | 40.6% |
| G0407 | Follow-up inpatient consultation, intermediate, physicians typically spend 25 minutes communicating with the patient via telehealth | Office | 2021 | 83 | 142 | $9,828 | $4,087 | 41.6% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2021 | 39 | 57 | $8,760 | $3,919 | 44.7% |
| G0408 | Follow-up inpatient consultation, complex, physicians typically spend 35 minutes communicating with the patient via telehealth | Office | 2021 | 36 | 44 | $7,158 | $3,443 | 48.1% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 13 | 18 | $1,122 | $923.58 | 82.3% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 14 | 14 | $904.00 | $896.60 | 99.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 17 | 17 | $476.00 | $270.13 | 56.8% |
About Dr. Pomilla Kumar, M.D
Dr. Pomilla Kumar, M.D is a Family Medicine healthcare provider based in Bettendorf, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1568431880.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Pomilla Kumar, M.D has received a total of $9,924 in payments from pharmaceutical and medical device companies, with $1,103 received in 2024. These payments were reported across 618 transactions from 59 companies. The most common payment nature is "Food and Beverage" ($9,902).
As a Medicare-enrolled provider, Kumar has provided services to 1,974 Medicare beneficiaries, totaling 3,871 services with total Medicare billing of $223,401. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Bettendorf, IA
- Active Since 03/17/2006
- Last Updated 03/07/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1568431880
Products in Payments
- REXULTI (Drug) $582.64
- ENTRESTO (Drug) $452.85
- Ozempic (Drug) $430.45
- XARELTO (Drug) $415.70
- BREZTRI (Drug) $344.73
- FARXIGA (Drug) $326.18
- VRAYLAR (Drug) $318.04
- Victoza (Drug) $296.30
- Kerendia (Drug) $295.35
- UBRELVY (Drug) $277.97
- ELIQUIS (Drug) $247.14
- Trintellix (Drug) $217.50
- SYMBICORT (Drug) $179.23
- Aimovig (Biological) $178.62
- Rybelsus (Drug) $178.37
- PREVNAR 13 (Biological) $160.21
- XIFAXAN (Drug) $158.34
- TRINTELLIX (Drug) $155.74
- VIBERZI (Drug) $142.23
- MOUNJARO (Drug) $141.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Bettendorf
Kayla Ehrman, D.o, D.O
Family Medicine — Payments: $150,263
Callina Elgar, D.o, D.O
Family Medicine — Payments: $4,747
Dr. Todd Wenck, Md, MD
Family Medicine — Payments: $3,978
Dr. Todd Letney, Md, MD
Family Medicine — Payments: $3,495
Dr. Jared Terronez, M.d, M.D
Family Medicine — Payments: $3,299
Dr. Lynn Geick, Md, MD
Family Medicine — Payments: $2,453